Related Experiment Video
Updated: Jun 8, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Latest developments in targeted therapy for hepatocellular carcinoma.
Liliana Montella1, Raffaele Addeo, Michele Caraglia
1Medical Oncology Unit, San Giovanni di Dio Hospital, via D. Pirozzi, 80027 Frattamaggiore, Naples, Italy. lilianamontella@libero.it
Expert Review of Anticancer Therapy
|October 15, 2010
Summary
Sorafenib marked a turning point for advanced hepatocellular carcinoma (HCC) treatment. Targeted therapies now offer selective cancer cell death, unlike traditional chemotherapy, opening new treatment avenues for this complex disease.
Area of Science:
- Oncology
- Hepatology
- Pharmacology
Background:
- Advanced hepatocellular carcinoma (HCC) historically had limited treatment options.
- Chemotherapy showed limited efficacy and selectivity in HCC.
- Sorafenib represented a breakthrough by targeting key signaling pathways.
Purpose of the Study:
- To review promising targeted drugs currently under investigation for HCC.
- To explore future therapeutic strategies for managing HCC.
- To highlight advancements in precision medicine for liver cancer.
Main Methods:
- Literature review of targeted therapies for HCC.
- Analysis of clinical trial data for novel HCC drugs.
- Discussion of pathogenetic mechanisms and signaling pathways in HCC.
Main Results:
- Sorafenib demonstrated improved outcomes in advanced HCC.
- Targeted drugs show potential for selective tumor cell killing.
- Multiple novel agents are in various stages of clinical development.
Conclusions:
- Targeted therapies are revolutionizing HCC treatment.
- Understanding HCC's complex mutational landscape is crucial for drug development.
- Future scenarios involve personalized treatment approaches based on molecular profiling.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...